{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:36:21Z","timestamp":1793118981804,"version":"4.5.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:sec id=\"ab-eoi250052-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Sufficient cycloplegia is essential for reliable refraction in preschool children. The choice of cycloplegic agent may affect refraction and diagnosis outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250052-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the objective refraction outcomes after cycloplegia in preschool children given either atropine or cyclopentolate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250052-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This was a post hoc analysis of the 2024 Preschool Children Refractive Development Pattern and Influencing Factors Study (PRDP-IFS), in which children were given atropine, and the 2013 to 2014 Elaborative Shanghai Childhood Ocular Refractive Development Study (E-SCORDS), in which children were given cyclopentolate. These were population-based studies. Eyes in each group were included via propensity score matching. Study data were analyzed from December 2024 to July 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250052-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Cycloplegia induced by either 1% atropine (twice daily for 4 days with an additional dose on day 5) or 1% cyclopentolate (dual administration 5 minutes apart) eye drops.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250052-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Difference between the noncycloplegic and cycloplegic spherical equivalent (DSE) and the prevalence of refractive states were compared in the atropine and cyclopentolate groups. Refractive states (moderate to high hyperopia, low hyperopia, premyopia, and myopia) were determined by cycloplegic spherical equivalent (SE) using an autorefractor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250052-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 1761 children and their 3048 eyes were included in this study. There were 773 children (1524 eyes) in the atropine group (mean [SD] age, 4.62 [0.92] years; 406 male [52.5%]) and 988 children (1524 eyes) in the cyclopentolate group (mean [SD] age, 4.62 [0.93] years; 530 male [53.6%]). There were a total of 1524 eyes in each group. The mean (SD) noncycloplegic SE was 0.30 (0.92) diopters (D) and 0.31 (0.76) D in the atropine and cyclopentolate groups, respectively (mean difference, \u22120.01 D; 95% CI, \u22120.07 to 0.05 D;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.72). Mean (SD) DSE in the atropine group was 1.56 (0.72) D and in the cyclopentolate group was 0.97 (0.70) D. The mean difference in DSE between the 2 groups was 0.59 D (95% CI, 0.54-0.64 D;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). The difference in the percentages of refractive states between the atropine and cycloplegic groups was as follows: moderate to high hyperopia (7.2% vs 2.7%\u2009=\u20094.5%; 95% CI, 2.9%-6.0%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), low hyperopia (82.8% vs 74.0%\u2009=\u20098.8%; 95% CI, 6.0%-11.8%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), premyopia (8.7% vs 21.6%\u2009=\u2009\u221212.9%; 95% CI, \u221215.4% to \u221210.4%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and myopia (1.3% vs 1.8%\u2009=\u2009\u22120.5%; 95% CI, \u22121.3% to 0.4%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.30).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi250052-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study found that use of atropine for cycloplegia in preschool children was associated with less myopic refraction compared with cyclopentolate and may potentially avoid overestimation of premyopia prevalence; however, this investigation did not evaluate each cycloplegic agent in the same children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2025.3243","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:31:05Z","timestamp":1758814265000},"page":"904","source":"Crossref","is-referenced-by-count":6,"title":["Atropine or Cyclopentolate to Diagnose Premyopia in Preschool Children"],"prefix":"10.1001","volume":"143","author":[{"given":"Haotian","family":"Wu","sequence":"first","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Rose","sequence":"additional","affiliation":[{"name":"Discipline of Orthoptics, Graduate School of Health, University of Technology Sydney, Ultimo, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Division of Biochemistry and Molecular Biology, Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Ni","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Xiang","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai, China"},{"name":"Department of Ophthalmology, The Affiliated People\u2019s Hospital of Ningbo University, The Eye Hospital of Wenzhou Medical University (Ningbo Branch), Ningbo, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Qi","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"},{"name":"Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangui","family":"He","sequence":"additional","affiliation":[{"name":"Shanghai Eye Diseases Prevention and Treatment Center\/Shanghai Eye Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"eoi250052r1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ophtha.2022.10.030","article-title":"Pediatric eye evaluations preferred practice pattern.","volume":"130","author":"Hutchinson","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi250052r2","first-page":"7","article-title":"Expert consensus on optometry and safe medication use for children with ciliary muscle paralysis.","volume":"55","author":"Chinese Medical Association Ophthalmology Branch Strabismus and pediatric Ophthalmology Group","year":"2019","journal-title":"Zhonghua Yan Ke Za Zhi\/Chin J Ophthalmol"},{"issue":"3","key":"eoi250052r4","doi-asserted-by":"publisher","first-page":"M184","DOI":"10.1167\/iovs.18-25977","article-title":"IMI\u2014clinical management guidelines report.","volume":"60","author":"Gifford","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi250052r5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/APO.0000000000000487","article-title":"How to conduct school myopia screening: comparison among myopia screening tests and determination of associated cutoffs.","volume":"11","author":"Wang","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"eoi250052r6","first-page":"388","article-title":"Brazilian guideline for pediatric cycloplegia and mydriasis.","volume":"86","author":"Curi","year":"2023","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"eoi250052r7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.51329\/mehdioptometry170","article-title":"Pediatric cycloplegic refraction.","volume":"4","author":"Eltagoury","year":"2023","journal-title":"Med Hypothesis Discov Innov Optom"},{"issue":"4","key":"eoi250052r8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jcrs.2004.10.068","article-title":"Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients.","volume":"31","author":"Hofmeister","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"eoi250052r9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cxo.13128","article-title":"Comparisons of atropine vs cyclopentolate cycloplegia in myopic children.","volume":"104","author":"Ye","year":"2021","journal-title":"Clin Exp Optom"},{"key":"eoi250052r10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5205946","article-title":"Refraction and ocular biometry of preschool children in Shanghai, China.","volume":"2018","author":"Zhang","year":"2018","journal-title":"J Ophthalmol"},{"issue":"14","key":"eoi250052r11","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1167\/iovs.16-20243","article-title":"Age-specific prevalence of visual impairment and refractive error in children aged 3-10 years in Shanghai, China.","volume":"57","author":"Ma","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi250052r12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","article-title":"Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report\u2013Part I.","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"issue":"3","key":"eoi250052r14","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","article-title":"IMI\u2014defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies.","volume":"60","author":"Flitcroft","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi250052r15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"5","key":"eoi250052r17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10384-018-0612-7","article-title":"Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study.","volume":"62","author":"Wakayama","year":"2018","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"eoi250052r18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/15569527.2013.808654","article-title":"Epileptic seizures induced by cycloplegic eye drops.","volume":"33","author":"Wygnanski-Jaffe","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"issue":"12","key":"eoi250052r19","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.4103\/IJO.IJO_1159_23","article-title":"Comparison of cycloplegia with atropine 1% vs cyclopentolate 1.","volume":"71","author":"Singh","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"eoi250052r20","first-page":"5","volume":"30","author":"Liu","year":"2012","journal-title":"Zhonghua Shiyan Yanke Zazhi\/Chin J Exp Ophthalmol"},{"issue":"2","key":"eoi250052r21","first-page":"7","volume":"58","author":"Public Health Ophthalmology Branch of the Chinese Preventive Medicine Association","year":"2022","journal-title":"Zhonghua Yan Ke Za Zhi\/Chin J Ophthalmol"},{"issue":"4","key":"eoi250052r22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/opo.12381","article-title":"The difference between cycloplegic and noncycloplegic autorefraction and its association with progression of refractive error in Beijing urban children.","volume":"37","author":"Lin","year":"2017","journal-title":"Ophthalmic Physiol Opt"},{"issue":"13","key":"eoi250052r23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33987","article-title":"Refractive and ocular biometric characteristics of nonmyopic and pseudomyopic eyes in mild hyperopic Chinese children aged 3-12 years.","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"eoi250052r24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10384-021-00828-6","article-title":"Difference of refractive status before and after cycloplegic refraction: the Lhasa Childhood Eye Study.","volume":"65","author":"Li","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"eoi250052r25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.64.11.4","article-title":"Baseline refractive error, habitual accommodative tone, and its association with myopia in children: the Lhasa Childhood Eye Study.","volume":"64","author":"Luo","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi250052r26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.ophtha.2012.01.017","article-title":"Annual changes in refractive errors and ocular components before and after the onset of myopia in Chinese children.","volume":"119","author":"Xiang","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi250052r27","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1167\/iovs.06-0562","article-title":"Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia.","volume":"48","author":"Mutti","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi250052r28","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.ophtha.2013.02.035","article-title":"Risk factors for incident myopia in Australian schoolchildren: the Sydney adolescent vascular and eye study.","volume":"120","author":"French","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi250052r29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/ceo.13195","article-title":"Cohort study with 4-year follow-up of myopia and refractive parameters in primary schoolchildren in Baoshan District, Shanghai.","volume":"46","author":"Ma","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"eoi250052r30","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of low-concentration atropine eye drops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial.","volume":"329","author":"Yam","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"eoi250052r31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9612","article-title":"Effect of repeated low-level red light on myopia prevention among children in china with premyopia: a randomized clinical trial.","volume":"6","author":"He","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"eoi250052r32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ophtha.2022.06.024","article-title":"Time outdoors in reducing myopia: a school-based cluster randomized trial with objective monitoring of outdoor time and light intensity.","volume":"129","author":"He","year":"2022","journal-title":"Ophthalmology"},{"key":"eoi250052r33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2024.08.020","article-title":"Spectacle lenses with highly aspherical lenslets for slowing axial elongation and refractive change in low-hyperopic chinese children: a randomized controlled trial.","volume":"269","author":"Zhang","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi250052r34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1167\/iovs.06-0604","article-title":"Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.","volume":"48","author":"Ebri","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"eoi250052r35","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1442-9071.2004.00863.x","article-title":"Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides.","volume":"32","author":"Fan","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"key":"eoi250052r36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ajo.2023.09.022","article-title":"Tropicamide vs cyclopentolate for cycloplegic refraction in pediatric patients with brown irides: a randomized clinical trial.","volume":"257","author":"Al-Thawabieh","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi250052r37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.optom.2017.09.001","article-title":"Comparison of cyclopentolate vs tropicamide cycloplegia: a systematic review and meta-analysis.","volume":"11","author":"Yazdani","year":"2018","journal-title":"J Optom"},{"issue":"8","key":"eoi250052r38","first-page":"1728","article-title":"Tropicamide (1%): an effective cycloplegic agent for myopic children.","volume":"42","author":"Manny","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi250052r39","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/OPX.0b013e3181cc8da3","article-title":"Comparison of 2 drug combinations for dilating dark irides.","volume":"87","author":"Anderson","year":"2010","journal-title":"Optom Vis Sci"},{"key":"eoi250052r3","volume-title":"Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease","author":"National Academies of Sciences, Engineering, and Medicine","year":"2024"},{"key":"eoi250052r13","volume-title":"Care of the Patient With Hyperopia: Reference Guide for Clinicians","author":"Moore","year":"1997"},{"key":"eoi250052r16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-68632-3","volume-title":"Pediatric Ophthalmology: Current Thought and A Practical Guide","author":"Wilson","year":"2009"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2839344\/jamaophthalmology_wu_2025_oi_250052_1762977500.58722.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T16:06:11Z","timestamp":1763654771000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2839344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.3243","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}